CTXRW - (Citius Pharmaceuticals Inc.)

 CTXRWのチャート


 CTXRWの企業情報

symbol CTXRW
会社名
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種   
概要 事業概要 --     
本社所在地 --
代表者氏名
代表者役職名
電話番号
設立年月日 --
市場名 --
ipoyear ―年
従業員数 -
url
nasdaq_url https://www.nasdaq.com/symbol/ctxrw
adr_tso
EBITDA EBITDA ー
終値(lastsale) 0.2432
時価総額(marketcap) 0
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 CTXRWのテクニカル分析


 CTXRWのニュース

   Citius Pharma To Spinoff Late-Stage Oncology Asset Into New Publicly Traded Firm  2022/05/25 14:13:01 Benzinga
Citius Pharmaceuticals Inc (NASDAQ: CTXR ) plans to form a new company (NewCo) focused on developing and commercializing I/ONTAK. A Phase 3 trial was completed in December 2021, and a biologics license application (BLA) is being planned for submission in the second half of 2022. The Company''s other pipeline assets, including Mino-Lok, would remain at Citius. Citius would continue to trade on the Nasdaq exchange … Full story available on Benzinga.com
   Citius Pharma to spinoff its immunotherapy I/ONTAK into a new publicly-traded company  2022/05/25 13:05:51 Seeking Alpha
Late-stage biopharmaceutical company Citius Pharmaceuticals (CTXR) on Wednesday said it plans to split into two separate publicly-traded entities.CTXR said it would form a new…
   Citius Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference on May 24, 2022  2022/05/18 13:30:00 PR Newswire
CRANFORD, N.J., May 18, 2022 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today announced that it will present at the H.C. Wainwright…
   Short Interest in Citius Pharmaceuticals, Inc. Expands By 25.0%  2022/05/17 16:49:09 Business Mag
Citius Pharmaceuticals, Inc. was the target of a significant growth in short interest in April. As of April 30th, there was short interest totalling 13,230,000 shares, a growth…
   Citius Pharmaceuticals GAAP EPS of -$0.05 beats by $0.02  2022/05/12 20:38:12 Seeking Alpha
Citius Pharmaceuticals press release (CTXR): Q2 GAAP EPS of -$0.05 beats by $0.02.Topline results of Phase 3 trial in cancer immunotherapy I/ONTAK consistent with prior formulation;…
   Citius Pharmaceuticals reports FY results  2021/12/15 21:41:45 Seeking Alpha
   Citius Pharmaceuticals Completes Enrollment in the Pivotal Phase 3 Study of its Cancer Immunotherapy I/ONTAK for the Treatment of Cutaneous T-Cell Lymphoma  2021/12/06 14:15:00 PR Newswire
CRANFORD, N.J., Dec. 6, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on oncology, anti-infective
   Up to Date Stock in Review: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), ENDRA Life Sciences Inc. (NASDAQ:NDRA)  2021/11/23 11:52:53 Stock Equity
Citius Pharmaceuticals, Inc. (CTXR) with the stream of -2.05% also noticed, India ENDRA Life Sciences Inc. (NDRA) encountered a rapid change of -9.11% in the last hour of Monday’s trading … The post Up to Date Stock in Review: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), ENDRA Life Sciences Inc. (NASDAQ:NDRA) appeared first on Stocks Equity .
   Citius Pharmaceuticals (NASDAQ:CTXR) Stock Rating Upgraded by Zacks Investment Research  2021/11/11 08:40:41 Dakota Financial News
Citius Pharmaceuticals (NASDAQ:CTXR) was upgraded by Zacks Investment Research from a sell rating to a hold rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective []
   Citius Pharmaceuticals Expands Management Team with Appointment of Kelly Creighton, PhD as Executive Vice President of Chemistry, Manufacturing and Controls  2021/11/05 13:15:00 PR Newswire
CRANFORD, N.J., Nov. 5, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on oncology, anti-infective
   Temple University Renames College of Liberal Arts Main Campus Building in Honor of Citius Pharmaceuticals Executive Chairman Leonard Mazur  2021/10/01 12:30:00 PR Newswire
CRANFORD, N.J., Oct. 1, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on oncology, anti-infective
   Citius Pharmaceuticals, Inc.: Burning Cash Before Commercialization  2021/09/26 06:28:31 Seeking Alpha
   Honest Ways To pick this stocks: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR 0.81%), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI 3.40%)  2021/09/21 23:32:09 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Honest Ways To pick this stocks: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR 0.81%), Infinity Pharmaceuticals, Inc. (NASDAQ:INFI 3.40%) appeared first on Stocks Equity .
   Why This Citius Analyst Thinks The Biopharma''s Shares Present 375% Upside Potential  2021/09/10 14:21:14 Business Insider Markets
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR ) announced earlier this week an agreement…
   Enslaving stocks: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR 0.95%), Zomedica Corp. (AMEX:ZOM -3.37%)  2021/09/07 22:55:55 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Enslaving stocks: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR 0.95%), Zomedica Corp. (AMEX:ZOM -3.37%) appeared first on Stocks Equity .

 関連キーワード  (― 米国株 CTXRW Citius Pharmaceuticals Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)